Schlegel Elisabeth F M, Blaho John A
Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Virology. 2009 May 10;387(2):449-58. doi: 10.1016/j.virol.2009.02.040.
Recombinant virus HSV-1(RF177) was previously generated to examine tegument protein VP22 function by inserting the GFP gene into the gene encoding VP22. During a detailed analysis of this virus, we discovered that RF177 produces a novel fusion protein between the last 15 amino acids of VP22 and GFP, termed GCT-VP22. Thus, the VP22 carboxy-terminal specific antibody 22-3 and two anti-GFP antibodies reacted with an approximately 28 kDa protein from RF177-infected Vero cells. GCT-VP22 was detected at 1 and 3 hpi. Examination of purified virions indicated that GCT-VP22 was incorporated into RF177 virus particles. These observations imply that at least a portion of the information required for virion targeting is located in this domain of VP22. Indirect immunofluorescence analyses showed that GCT-VP22 also localized to areas of marginalized chromatin during RF177 infection. These results indicate that the last fifteen amino acids of VP22 participate in virion targeting during HSV-1 infection.
重组病毒单纯疱疹病毒1型(RF177)是之前通过将绿色荧光蛋白(GFP)基因插入编码VP22的基因中构建而成,用于研究包膜蛋白VP22的功能。在对该病毒进行详细分析的过程中,我们发现RF177产生了一种新型融合蛋白,它由VP22的最后15个氨基酸与GFP组成,被命名为GCT-VP22。因此,VP22羧基末端特异性抗体22-3和两种抗GFP抗体与来自RF177感染的非洲绿猴肾细胞(Vero细胞)中的一种约28 kDa的蛋白发生反应。在感染后1小时和3小时检测到了GCT-VP22。对纯化病毒粒子的检测表明,GCT-VP22被整合到RF177病毒颗粒中。这些观察结果表明,病毒体靶向所需的至少一部分信息位于VP22的这个结构域中。间接免疫荧光分析显示,在RF177感染期间,GCT-VP22也定位于边缘化染色质区域。这些结果表明,VP22的最后15个氨基酸在单纯疱疹病毒1型感染过程中参与病毒体靶向。